Regenxbio Stock In The News

RGNX Stock  USD 6.72  0.17  2.60%   
Our overall analysis of Regenxbio's news coverage and content from conventional and social sources shows investors' bearish mood towards Regenxbio. The specific impact of Regenxbio news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Regenxbio's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Regenxbio headlines in addition to utilizing other, more conventional financial analysis modules. Check out Regenxbio Backtesting and Regenxbio Hype Analysis.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Regenxbio Today Top News and Investor Outlook

Yahoo News
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
https://finance.yahoo.com/news/regenxbios-gene-therapy-outlook-dims-202040472.html
 Bullish
Yahoo News
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
https://finance.yahoo.com/news/abbvie-regenxbio-announce-updates-abbv-133100986.html
 Neutral
Yahoo News
JPMorgan Chase & Co. Reduces Stake in Regenxbio Inc
https://finance.yahoo.com/news/jpmorgan-chase-co-reduces-stake-190438875.html
 Neutral
Yahoo News
7 Biotech Stocks to Buy for Their Game-Changing Potential
https://finance.yahoo.com/news/7-biotech-stocks-buy-game-100000015.html
 Neutral
Yahoo News
7 Biotech Stocks to Buy on the Dip: June 2024
https://finance.yahoo.com/news/7-biotech-stocks-buy-dip-165610937.html
 Bullish
Yahoo News
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/regenxbio-inc-nasdaq-rgnx-q4-143631944.html
 Bullish
Yahoo News
Regenxbio Inc President and CEO Kenneth Mills Sells 45,000 Shares
https://finance.yahoo.com/news/regenxbio-inc-president-ceo-kenneth-020122028.html
 Bullish
Yahoo News
REGENXBIO Announces Positive Interim Dat...
https://finance.yahoo.com/news/regenxbio-announces-positive-interim-data-194700208.html
 Bullish
Yahoo News
REGENXBIO Announces Presentation at the Hawaiian Eye and Retina 2024 Meeting
https://finance.yahoo.com/news/regenxbio-announces-presentation-hawaiian-eye-120500478.html
 Neutral
Yahoo News
Down -25.53% in 4 Weeks, Here's Why You Should You Buy the Dip in Regenxbio (RGNX)
https://finance.yahoo.com/news/down-25-53-4-weeks-232011862.html
 Bullish

Regenxbio Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Regenxbio and other traded companies coverage with news coverage. We help investors stay connected with Regenxbio headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Regenxbio Stock performance. Please note that trading solely based on the Regenxbio hype is not for everyone as timely availability and quick action are needed to avoid losses.
Regenxbio's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Regenxbio investors visualize upcoming and past events in order to time the market based on Regenxbio noise-free hype analysis.
Regenxbio stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Regenxbio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Regenxbio that are available to investors today. That information is available publicly through Regenxbio media outlets and privately through word of mouth or via Regenxbio internal channels. However, regardless of the origin, that massive amount of Regenxbio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Regenxbio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Regenxbio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Regenxbio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Regenxbio alpha.

Regenxbio Largest EPS Surprises

Earnings surprises can significantly impact Regenxbio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-11-07
2018-09-30-0.44-0.56-0.1227 
2016-03-03
2015-12-31-0.34-0.20.1441 
2023-02-28
2022-12-31-1.23-1.38-0.1512 
2024-02-27
2023-12-31-1.27-1.43-0.1612 
2020-05-07
2020-03-31-0.87-1.08-0.2124 
2019-11-05
2019-09-30-0.71-0.94-0.2332 
View All Earnings Estimates

Regenxbio Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Regenxbio Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
13th of March 2025
Regenxbio Inc Q4 2024 Earnings EPS Beats Estimates at -1.01, Revenue Misses at 21. ...
at gurufocus.com 
Yahoo News
6th of March 2025
Jim Cramer on REGENXBIO Inc. This Thing Just Does Nothing But Go Down
at finance.yahoo.com 
Yahoo News
4th of March 2025
REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases
at finance.yahoo.com 
zacks News
20th of February 2025
Castle Biosciences, Inc. Reports Next Week Wall Street Expects Earnings Growth
at zacks.com 
Gurufocus Stories at Macroaxis
14th of February 2025
Aquilo Capital Management, LLC Increases Stake in Precision BioSciences Inc
at gurufocus.com 
benzinga news
11th of February 2025
Regenxbios Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
at benzinga.com 
news
7th of February 2025
Raymond James Initiates Coverage on REGENXBIO
at thelincolnianonline.com 
Simply Wall St News at Macroaxis
5th of February 2025
Investors in REGENXBIO from five years ago are still down 84, even after 11 percent gain t...
at simplywall.st 
Gurufocus Stories at Macroaxis
31st of January 2025
Vanguard Group Inc Reduces Stake in Regenxbio Inc
at gurufocus.com 
bizjournals News
14th of January 2025
Rockvilles RegenxBio strikes potential 810M deal with Japans Nippon Shinyaku
at bizjournals.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Regenxbio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Regenxbio's short interest history, or implied volatility extrapolated from Regenxbio options trading.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.